Lancet Psychiatry. 2019
Furukawa TA, et al. Optimal dose of selective serotonin reuptake inhibitors (SSRIs), venlafaxine, and mirtazapine in major depression: A systematic review and dose-response meta-analysis.
In brief
This study provided evidence of the possible existence of a dose-response relationship with venlafaxine.
Background
Depression is a major contributor to disability, affecting 322 million people or 4.4% of the world’s population.
January 17, 2023
